Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sambataro

Showing results (471-480 of 493) with videos related to

Pageof 50
Sort By:
The Lancet. Oncology|April 18, 2015
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trialSandro Pignata, Domenica Lorusso, Giovanni Scambia, et al.
Scientific Reports|March 8, 2018
Cerebral blood flow predicts differential neurotransmitter activityJuergen Dukart, Štefan Holiga, Christopher Chatham, et al.
Psychiatry Research. Neuroimaging|January 22, 2026
Impact of genetic variants on hippocampal volume among individuals with schizophrenia and bipolar disordersTommaso Toffanin, Giulia Ida Perini, Halima Follador, et al.
Gynecologic Oncology|June 24, 2023
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi studyNicoletta Colombo, Angiolo Gadducci, Fabio Landoni, et al.
Nature Medicine|May 5, 2009
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophreniaStephen J Huffaker, Jingshan Chen, Kristin K Nicodemus, et al.
The Lancet. Oncology|February 4, 2021
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trialSandro Pignata, Domenica Lorusso, Florence Joly, et al.
Rivista Di Psichiatria|April 17, 2025
[Assisted suicide for patients suffering from severe depression. An unacceptable option that psychiatrists must fight with all their strength.]Giovanni de Girolamo, Andrea Angelozzi, Anna Rita Atti, et al.
Microorganisms|July 8, 2020
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern ItalyLorenzo Cavagna, Elena Seminari, Giovanni Zanframundo, et al.
Anticancer Research|May 27, 2025
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast CancerVincenzo Iorio, Pietro Delia, Angela Pia Solazzo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2021
The polysemous concepts of psychomotricity and catatonia: A European multi-consensus perspectiveJack R Foucher, Ludovic C Jeanjean, Clément C de Billy, et al.
Pageof 50

Showing results (471-480 of 493) with videos related to

Sort By:
Pageof 50
The Lancet. Oncology|April 18, 2015
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trialSandro Pignata, Domenica Lorusso, Giovanni Scambia, et al.
Scientific Reports|March 8, 2018
Cerebral blood flow predicts differential neurotransmitter activityJuergen Dukart, Štefan Holiga, Christopher Chatham, et al.
Psychiatry Research. Neuroimaging|January 22, 2026
Impact of genetic variants on hippocampal volume among individuals with schizophrenia and bipolar disordersTommaso Toffanin, Giulia Ida Perini, Halima Follador, et al.
Gynecologic Oncology|June 24, 2023
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi studyNicoletta Colombo, Angiolo Gadducci, Fabio Landoni, et al.
Nature Medicine|May 5, 2009
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophreniaStephen J Huffaker, Jingshan Chen, Kristin K Nicodemus, et al.
The Lancet. Oncology|February 4, 2021
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trialSandro Pignata, Domenica Lorusso, Florence Joly, et al.
Rivista Di Psichiatria|April 17, 2025
[Assisted suicide for patients suffering from severe depression. An unacceptable option that psychiatrists must fight with all their strength.]Giovanni de Girolamo, Andrea Angelozzi, Anna Rita Atti, et al.
Microorganisms|July 8, 2020
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern ItalyLorenzo Cavagna, Elena Seminari, Giovanni Zanframundo, et al.
Anticancer Research|May 27, 2025
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast CancerVincenzo Iorio, Pietro Delia, Angela Pia Solazzo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2021
The polysemous concepts of psychomotricity and catatonia: A European multi-consensus perspectiveJack R Foucher, Ludovic C Jeanjean, Clément C de Billy, et al.
Pageof 50